# Fate Therapeutics Inc: Form SC 13D/A, filed Jan 12, 2021

- Company: [Fate Therapeutics Inc](/companies/fate.md) (CIK 1434316)
- Form: SC 13D/A
- Filed: 2021-01-12
- Accepted by EDGAR: Jan 12, 2021, 16:18 ET
- Period: not reported
- Accession: 0001104659-21-003451
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1434316/000110465921003451/tm212903d1_sc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434316/000110465921003451/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434316/000110465921003451/tm212903d1_sc13da.htm

Filed Jan 12, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-003451. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
